Knud Landmark
Impact in
-
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Cardiac Arrhythmias and Treatments
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Cardiac electrophysiology and arrhythmias 34
- Blood Pressure and Hypertension Studies 10
- Cardiac Arrhythmias and Treatments 9
- Cardiovascular Function and Risk Factors 8
-
- Electrochemical Analysis and Applications 8
Knud Landmark
91 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 108
- Cardiology and Cardiovascular Medicine 921
- Biochemistry 110
- Nutrition and Dietetics 231
- Electrochemistry 60
- Radiology, Nuclear Medicine and Imaging 177
Countries citing papers authored by Knud Landmark
This map shows the geographic impact of Knud Landmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knud Landmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knud Landmark more than expected).
Fields of papers citing papers by Knud Landmark
This network shows the impact of papers produced by Knud Landmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knud Landmark. The network helps show where Knud Landmark may publish in the future.
Co-authors
The 25 scholars most cited alongside Knud Landmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 9 | |
| 2 | 2012 | 12 | |
| 3 | 2012 | 1 | |
| 4 | [Alpha-linolenic acid, cardiovascular disease and sudden death]. | 2006 | 8 |
| 5 | ACE-hemmer eller AII-reseptorblokker ved hjertesvikt og hjerteinfarkt? | 2005 | 0 |
| 6 | [Can hydrochlorothiazide and chlorthalidone be compared in the treatment of hypertension?]. | 2004 | 1 |
| 7 | 2003 | 1 | |
| 8 | [Hypokalemia can accelerate the development of cerebrovascular and cardiovascular disease]. | 2002 | 3 |
| 9 | 2001 | 162 | |
| 10 | 1998 | 26 | |
| 11 | 1998 | 16 | |
| 12 | Nitrendipine and mefruside in elderly hypertensives: effects on blood pressure, cardiac output, cerebral blood flow and metabolic parameters. | 1995 | 10 |
| 13 | 1992 | 5 | |
| 14 | 1984 | 103 | |
| 15 | 1981 | 6 | |
| 16 | 1978 | 66 | |
| 17 | 1977 | 1 | |
| 18 | 1976 | 12 | |
| 19 | 1973 | 6 | |
| 20 | 1972 | 9 |
About Knud Landmark
Knud Landmark is a scholar working on Cardiology and Cardiovascular Medicine, Electrochemistry, Nutrition and Dietetics, Biophysics and Geriatrics and Gerontology, having authored 97 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (34 papers), Ion channel regulation and function (17 papers), Blood Pressure and Hypertension Studies (10 papers), Cardiac Arrhythmias and Treatments (9 papers), Cardiovascular Function and Risk Factors (8 papers), Electrochemical Analysis and Applications (8 papers), Neuroscience and Neural Engineering (8 papers) and Receptor Mechanisms and Signaling (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (921 citations), Biochemistry (110 citations), Nutrition and Dietetics (231 citations), Electrochemistry (60 citations) and Radiology, Nuclear Medicine and Imaging (177 citations). Knud Landmark has collaborated with scholars based in Norway, Czechia and Germany. Frequent co-authors include Svein Simonsen, Jarle Holen, Rune Aaslid, Helge Refsum, Jon Dale, Jan Amlie, Erik Myhre, O Storstein, Leik Woie and Grethe Albrektsen. Their work appears in journals such as European Journal of Pharmacology, Cardiovascular Research, European Journal of Clinical Pharmacology, Journal of Cardiovascular Pharmacology and Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.